7301 - 7325 of 8100 Results
Title
Year
- Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients2013OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: https://europepmc.org/articles/pmc3859714?pdf=renderCitation Count: 7
- Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study2013OPENTitle: Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 10Start Page: 978End Page: 988Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70210-2Best OA location URL: https://europepmc.org/articles/pmc3879782?pdf=renderCitation Count: 257
-
OPENTitle: Parkinsonism syndrome in heterozygotes for Niemann–Pick C1Journal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 335Issue #: 1-2Start Page: 219End Page: 220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2013.08.033Best OA location URL: https://europepmc.org/articles/pmc4729292?pdf=renderCitation Count: 65
- 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model2013RESTRICTEDTitle: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease modelJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 60Issue #:Start Page: 108End Page: 114Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014Citation Count: 50
- Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models2013RESTRICTEDTitle: Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian modelsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 57Issue #:Start Page: 38End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.06.025Best OA location URL: https://europepmc.org/articles/pmc3815566?pdf=renderCitation Count: 152
- Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s Disease2013OPENTitle: Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s DiseaseJournal Name: NeuronPublisher: Elsevier BVVol: 79Issue #: 5Start Page: 873End Page: 886Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2013.06.046Best OA location URL: http://www.cell.com/article/S089662731300562X/pdfCitation Count: 342
- P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease2013RESTRICTEDTitle: P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s diseaseJournal Name: Neuromuscular DisordersPublisher: Elsevier BVVol: 23Issue #: 9-10Start Page: 836End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nmd.2013.06.684Citation Count: 1
- Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo2013OPENTitle: Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivoJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 110Issue #: 41Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1309991110Best OA location URL: https://www.pnas.org/content/pnas/110/41/E3945.full.pdfCitation Count: 163
- Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease2013OPENTitle: Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.3861Best OA location URL: https://europepmc.org/articles/pmc4034348?pdf=renderCitation Count: 354
-
OPENTitle: Insight into α-Synuclein Plasticity and Misfolding from Differential Micelle BindingJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 117Issue #: 39Start Page: 11448End Page: 11459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jp402589xBest OA location URL: https://europepmc.org/articles/pmc3946565?pdf=renderCitation Count: 11
- Pesticides that inhibit the ubiquitin–proteasome system: Effect measure modification by genetic variation in SKP1 in Parkinson׳s disease2013OPENTitle: Pesticides that inhibit the ubiquitin–proteasome system: Effect measure modification by genetic variation in SKP1 in Parkinson׳s diseaseJournal Name: Environmental ResearchPublisher: Elsevier BVVol: 126Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.envres.2013.08.001Best OA location URL: https://escholarship.org/content/qt3295g553/qt3295g553.pdf?t=no8lj2Citation Count: 48
-
RESTRICTEDTitle: MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat modelJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 553Issue #:Start Page: 153End Page: 158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.08.001Citation Count: 60
- The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants2013OPENTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://research-repository.griffith.edu.au/bitstream/10072/67208/1/MellickPUB29.pdfCitation Count: 37
-
RESTRICTEDTitle: Cholinergic Dysfunction in Parkinson’s DiseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-013-0377-9Best OA location URL: https://europepmc.org/articles/pmc3991467?pdf=renderCitation Count: 200
-
OPENTitle: Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycleJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 456Issue #: 1Start Page: 119End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1042/bj20121772Best OA location URL: https://europepmc.org/articles/pmc5141581?pdf=renderCitation Count: 88
-
OPENTitle: Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 LocusJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 8Start Page: e70724End Page: e70724Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0070724Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0070724&type=printableCitation Count: 45
-
OPENTitle: TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiencyJournal Name: Annals of NeurologyPublisher: WileyVol: 74Issue #: 6Start Page: 837End Page: 847Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ana.23999Best OA location URL: https://doi.org/10.1002/ana.23999Citation Count: 80
- Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium2013OPENTitle: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortiumJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1740End Page: 1744Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25600Best OA location URL: https://europepmc.org/articles/pmc4108155?pdf=renderCitation Count: 34
-
OPENTitle: A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1Journal Name: CellPublisher: Elsevier BVVol: 154Issue #: 4Start Page: 737End Page: 747Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2013.07.030Best OA location URL: http://www.cell.com/article/S009286741300901X/pdfCitation Count: 240
- Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease2013OPENTitle: Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 91Issue #: 10Start Page: 1292End Page: 1302Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.23253Best OA location URL: https://europepmc.org/articles/pmc5800426?pdf=renderCitation Count: 56
- Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson’s Disease2013OPENTitle: Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 8Start Page: e70274End Page: e70274Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0070274Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0070274&type=printableCitation Count: 168
-
RESTRICTEDTitle: Surgical Treatment of Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 31Issue #: 3Start Page: 799End Page: 808Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2013.03.007Best OA location URL: https://europepmc.org/articles/pmc3728709?pdf=renderCitation Count: 36
-
OPENTitle: LRRK2 secretion in exosomes is regulated by 14-3-3Journal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 22Issue #: 24Start Page: 4988End Page: 5000Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddt346Best OA location URL: https://academic.oup.com/hmg/article-pdf/22/24/4988/14140078/ddt346.pdfCitation Count: 156
- Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s Disease2013OPENTitle: Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 2169End Page: 2180Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2013.169Best OA location URL: http://www.cell.com/article/S1525001616309431/pdfCitation Count: 53
-
OPENTitle: Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson′s diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1531Issue #:Start Page: 37End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2013.07.025Best OA location URL: https://europepmc.org/articles/pmc3816277?pdf=renderCitation Count: 28